Patents Examined by Dinah Baria
  • Patent number: 10842626
    Abstract: A device structured to suppress mitral regurgitation by restricting prolapse of a mitral valve leaflet and including a base correspondingly dimensioned to the mitral valve and including a central portion, structured to allow blood flow there through and a peripheral portion or ring connected to the central portion in substantially surrounding relation thereto. An operative position of the base includes the central portion disposed in overlying, movement restricting relation to at least one of the valve leaflets and the ring concurrently anchored adjacent or directly to the native annulus of the mitral valve. The physical characteristics of the base facilitate its movement with and conformance to the mitral valve during diastole and systole cycles of the heart.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: November 24, 2020
    Inventor: Didier de Canniere
  • Patent number: 10842911
    Abstract: Provided are an alloy member which is usable in organisms, makes use of features of bio-affinity and biodegradability of magnesium, and is able to realize required duration of biodegradability, and a production method therefor. According to the present invention, the alloy member usable in organisms includes a base body that contains a magnesium alloy, a first protective layer that contains an oxide derived from a component of the base body or a complex of an oxide and a hydroxide derived from a component of the base body, and a second protective layer that contains a hydroxide derived from a component of the base body.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: November 24, 2020
    Assignees: FUJI LIGHT METAL CO., LTD., NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY, MEL-FRONTIER, LTD.
    Inventors: Hironori Ueda, Masashi Inoue, Kotaro Hanada
  • Patent number: 10842969
    Abstract: Systems, devices, and methods for maintaining patency in a bronchus of a patient are presented. A catheter is positioned within the bronchus. A target region of one or more of a bronchial wall, submucosa, media, and adventitia is punctured with an injection needle disposed on a distal end of the catheter. Such puncturing is achieved by expanding a balloon disposed on the distal end of the catheter. The balloon may be comprised of at least two materials of different elastic modulus, which allows for a flexible but relatively non-distensible, unfolding component of the balloon as well as an elastomeric, inflatable component of the balloon. Through the injection needle, an amount of one or more crosslinking agents is delivered to the target region. The delivered amount is effective to provide structural support for the bronchial wall, substituting for the bronchial cartilage thereby treating bronchomalacia.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: November 24, 2020
    Assignee: MERCATOR MEDSYSTEMS, INC.
    Inventor: Kirk Patrick Seward
  • Patent number: 10835646
    Abstract: A system for preventing thrombosis in an implantable medical device includes an implantable medical device sized for implantation at least partially within a patient's body. The device includes an at least partially electrically conductive portion that is disposed within a patient's body upon implantation, an electrode coupled to the electrically conductive portion of the device; and a power source coupled to the electrode. The power source provides a negative electric charge to the at least partially electrically conductive portion for an indefinite period of time. The device may be configured to resist thrombosis, infection, and/or undesired tissue growth via the charged conductive portion once implanted. Exemplary embodiments of the implantable medical device include a hemodialysis vasculature graft, a dialysis catheter, a coronary artery, and a heart valve.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: November 17, 2020
    Inventor: Timothy J. Ryan
  • Patent number: 10820988
    Abstract: An expandable stent-valve has a stent component and a valve component, preferably an aortic valve component, a mitral valve component or a tricuspid valve component. The stent has, an outer surface area structured in a manner such that the surface area has a higher coefficient of friction between the outer surface and a duct wall than an untreated surface area of the stent component. The surface area is preferably structured with micro-incisions or micro-grooves.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: November 3, 2020
    Assignee: EPYGON
    Inventors: Marcio Scorsin, Enrico Pasquino
  • Patent number: 10820985
    Abstract: The present invention relates to a prosthetic capsular bag and method for inserting the same. The prosthetic capsular bag helps to maintain the volume of the natural capsular bag, thereby stabilizing the effective lens position of an IOL so that refractive outcomes may be improved with cataract surgery. The prosthetic capsular bag further provides an integrated refractive surface, providing a means for experimentally determining an effective lens position prior to inserting an IOL.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: November 3, 2020
    Assignee: Omega Ophthalmics LLC
    Inventor: Gary N. Wortz
  • Patent number: 10779928
    Abstract: The invention relates to a suction stent for introduction into a hollow organ of the human or animal body, preferably into the gastrointestinal tract, in particular the intestine, comprising a tubular hollow body which is open in the longitudinal direction and made of biocompatible material, the tubular hollow body having a fixed diameter at least in its central portion; and a porous shapeable material, preferably a sponge material, which is biocompatible and shapeable in the radial direction, the porous shapeable material radially sheathing the tubular hollow body at least in a section of the tubular hollow body. Further, the invention relates to a method for sealing a leakage, especially an anastomosis, of the hollow organ.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: September 22, 2020
    Assignee: Vac Stent Medtec AG
    Inventor: Markus M. Heiss
  • Patent number: 10765534
    Abstract: A method of implanting a humeral component includes accessing a humerus and resecting a head portion of the humerus to form a resected surface. The method further includes selecting a first combination sizer and guide device having an outer surface sized complementary to a desired implant head size, positioning the selected first combination sizer and guide device on the resected surface, guiding placement of a guide pin in the humerus with the first combination sizer and guide device, guiding a reamer with the placed guide pin to form a reamed cavity in the humerus, positioning an anchoring portion of a humeral implant base portion in the reamed cavity, positioning the first combination sizer and guide device on the base portion, removing the first combination sizer and guide device from the base portion, and positioning an implant head on the base portion.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: September 8, 2020
    Assignee: DePuy Synthes Products, Inc.
    Inventor: Patrick McElhaney, Jr.
  • Patent number: 10751171
    Abstract: A prosthetic heart valve includes a stent having a collapsed condition and an expanded condition. The stent includes a plurality of cells, each cell being formed by a plurality of struts, and a plurality of commissure features. The heart valve further includes a valve assembly secured to the stent and including a cuff and a plurality of leaflets, each leaflet being attached to adjacent commissure features and to the stent struts and/or the cuff.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: August 25, 2020
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventors: Xue Mei Li, Peter N. Braido
  • Patent number: 10751201
    Abstract: An intracorporeal portion of a percutaneous device for a joint disarticulation prosthesis or joint replacement prosthesis, the intracorporeal portion having an extracorporeal portion or having means for rigidly coupling directly to an extracorporeal portion, the extracorporeal portion being for location exterior to the skin, the intracorporeal portion having an articulating component for articulating with an articulating surface, wherein the articulating component is intracorporeal when installed in a human or animal subject.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: August 25, 2020
    Assignee: Stanmore Implants Worldwide Limited
    Inventors: Paul Unwin, Gordon Blunn
  • Patent number: 10743986
    Abstract: The present disclosure includes a method that includes inserting an implant proximate a mitral valve, the implant comprising a tubular body and a plurality of piercing members, the tubular body comprising an upper diameter and a lower diameter. The method also includes engaging tissue proximate the mitral valve by the plurality of piercing members and transitioning the tubular body from a first structural configuration to a second structural configuration by application of an expansive force to the tubular body proximate the upper diameter, the first structural configuration having the upper diameter smaller than the lower diameter and the second structural configuration having the upper diameter larger than the lower diameter. The present disclosure also includes associated systems and implants.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: August 18, 2020
    Assignee: BOSTON SCIENTIFIC SCIMED INC.
    Inventor: Randall Lashinski
  • Patent number: 10744232
    Abstract: Antimicrobial catheters and medical devices are provided. In some aspects, a low durometer aliphatic polyether polyurethane may be impregnated with a first antimicrobial agent (e.g., minocycline and rifampin) and coated with a second antimicrobial agent (e.g., chlorhexidine, gendine, or gardine). The antimicrobial catheters may display improved flexibility and resistance to kinking. Methods of producing the antimicrobial catheters are also provided.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: August 18, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Joel Rosenblatt, Issam Raad
  • Patent number: 10736995
    Abstract: An intermixed particulate bioresorbable material including cathodic particles and anodic particles bound to each other, wherein the anodic and cathodic particles are made respectively of an anodic and a cathodic material, the anodic and cathodic materials forming a galvanic couple. The anodic and cathodic particles are present in a predetermined ratio and the anodic particles, cathodic particles and predetermined ratio are such that bioresorption of the bioresorbable material is promoted by galvanic corrosion between the anodic and cathodic materials. Also, a medical device, manufactured using the bioresorbable material and a method of manufacturing the bioresorbable material and the medical device.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: August 11, 2020
    Assignee: LES ENTREPRISES NANOSTENT INC.
    Inventors: Rosaire Mongrain, Olivier Francois Bertrand, Stephen Yue
  • Patent number: 10729832
    Abstract: A blood pump, such as an axial flow pump, having a pump housing, the pump housing defining a flow path and having a tapered portion adjacent to an outlet, tapering toward the outlet, an outflow cannula connected to the outlet of the pump housing, and an impeller and diffuser, disposed in the pump housing, the diffuser having a tapered body corresponding to the tapered portion of the pump housing, the diffuser body having at least one vane extending therefrom, the vein tapering in the same direction as the diffuser body. The present invention also includes a method of manufacturing the blood pump and a method of implanting the blood pump.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: August 4, 2020
    Assignee: HeartWare, Inc.
    Inventor: Mustafa Ertan Taskin
  • Patent number: 10702635
    Abstract: A device for evacuating a surgical site of a patient includes a container that defines a first end having a surgical site engaging surface and a second end having a pressure source engaging surface. The first end defines a tapered cross-section configured for being engageably received within an opening at the surgical site. In operation, vacuum pressure is applied to the second end in order to create a vacuum within the container to evacuate fluids from the surgical site.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: July 7, 2020
    Assignee: A LaRue Company
    Inventors: Angela Vargo LaRue, Charles Channing LaRue, Paul Bradley Forrest
  • Patent number: 10675151
    Abstract: Disclosed herein are an implant with a suture passage and a method of attaching sutures to the same. The implant may include a suture pocket having a first pocket, a second pocket, and a suture hole disposed therebetween. The first pocket may have a first wall segment, the second pocket may have a second wall segment, and the suture hole may have a first sidewall segment extending from a first opening to a second opening. The first wall segment, the second wall segment, and the first sidewall segment may form a contiguous wall. A method of attaching a suture to the implant may include placing a tip of a suture needle on the first wall segment, sliding the suture needle into the first opening and pushing the suture needle through the suture hole.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: June 9, 2020
    Assignee: Howmedica Osteonics Corp.
    Inventors: Rajan Yadav, David Viscardi, Koustubh Rao, Nicholas Olson, Roy Philip Splieth
  • Patent number: 10675467
    Abstract: One aspect of the present disclosure relates to a system for treating obstructive sleep apnea in a subject. The system can include a power source and a neuromuscular stimulator in electrical communications with the power source. The neuromuscular stimulator can include a controller and at least one electrode. The controller can be configured to receive certain power and stimulation parameters associated with a therapy signal from the power source. The at least one electrode can be configured to deliver the therapy signal to a target tissue associated with control of a posterior base of the tongue of the subject.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: June 9, 2020
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventor: Francis A. Papay
  • Patent number: 10667921
    Abstract: An implant can be used for the treatment of fat pad atrophy. The implant can be installed in the ball of the foot, the heel of the foot, the hands, or other areas. The implant can supplement or replace a patient's fat pads. In some instances, the implant can include an implant pad having a non-permeable external lining and an internal cavity enclosed by the external lining. The internal cavity can include a filler material. The implant can include features that resist rupture and/or migration.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: June 2, 2020
    Assignee: ET MEDICAL TECHNOLOGIES, LLC
    Inventors: Richard Mangione, Tony Ray Meyer, Jr., Einat Lampert
  • Patent number: 10653519
    Abstract: An implant and method for repairing and/or replacing functionality of a native mitral valve are in various embodiments configured to reduce or eliminate mitral regurgitation and residual mitral valve leakage. A coiled anchor with a central turn that reduces in size upon implantation is used to approximate the amount of reduction in the size and the reshaping of the native mitral annulus to reduce valve leakage. A clip can be further applied to the native valve leaflets to reduce the size of the native mitral annulus and leakage therethrough. A prosthetic heart valve can be implanted in the coiled anchor to replace and further improve functionality of the valve. In some cases, the prosthetic valve can be implanted in a clipped valve, where the clip is detached from one of the native valve leaflets to provide space for the prosthetic valve to expand.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: May 19, 2020
    Assignee: Mitral Valve Technologies Sarl
    Inventors: Paul A. Spence, Landon H. Tompkins
  • Patent number: 10639158
    Abstract: Disclosed herein are patient-specific facial or craniofacial implants structured for filling bone voids in the cranium and face as well as for simultaneously providing soft tissue reconstruction and/or augmentation for improved aesthetic symmetry and appearance of face and skull. Pterional or temporal voids or defects generally result from a chronic skull or lateral facial deformity along with a compromised temporalis muscle or soft tissue distortion from previous surgery. When muscle atrophy occurs in the pterion or temporal face, temporal hollowing deformity generally results where there would be soft tissue but for the atrophy. The patient-specific temporal implants with dual-purpose herein are configured to have an augmented region adjacent the temporal region of the face and cranium in order to prevent and/or correct any such temporal hollowing deformity.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: May 5, 2020
    Assignee: Plastic Surgery LLC
    Inventor: Chad Gordon